CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.

@article{Siberry2011CD4LI,
  title={CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.},
  author={George K. Siberry and Kunjal Patel and Russell B. van Dyke and Rohan Hazra and Sandra K. Burchett and Stephen A Spector and Mary E. Paul and Jennifer S. Read and Andrew A. Wiznia and George R. Iii Seage},
  journal={Journal of acquired immune deficiency syndromes},
  year={2011},
  volume={57 3},
  pages={
          223-9
        }
}
OBJECTIVE To assess the characteristics and outcomes of antiretroviral treatment (ART) interruption (TI) in perinatally HIV-infected children. DESIGN The Adolescent Master Protocol (AMP) of the Pediatric HIV/AIDS Cohort Study is a prospective cohort study that enrolled 7- to 16-year-old perinatally HIV-infected children between 2007 and 2009 from 15 sites in the United States and Puerto Rico. METHODS TI was defined as ART discontinuation for ≥ 3 months after ≥ 6 months of continuous ART… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 15 REFERENCES

Impact of CD4+ T cell count on the outcome of planned treatment interruptions in earlytreated HIV-infected children

  • C Fortuny, A Noguera-Julian, L Alsina
  • Pediatr Infect Dis J. ;30:435–438
  • 2011
2 Excerpts